Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Isobutyramide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isobutyramide SCHEMBL7569768 | 1.00 | LMNA (0.43) | — | |
| Isobutyramide SCHEMBL2548633 | 1.00 | — | — | |
| Isobutyramide SCHEMBL27949096 | 0.96 | — | — | |
| Isobutyramide SCHEMBL2829019 | 0.96 | — | — | |
| Isobutyramide SCHEMBL3323 | 0.96 | — | — | |
| Isobutyramide SCHEMBL11109750 | 0.96 | LMNA (0.46) | — | |
| Isobutyramide SCHEMBL7773728 | 0.92 | — | — | |
| Isobutyramide SCHEMBL22719097 | 0.92 | — | — | |
| Isobutyramide SCHEMBL5830040 | 0.92 | — | — | |
| Isobutyramide SCHEMBL7090821 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060205938-A1 | Monohydrate solvates of loracarbef | RANBAXY LABORATORIES LIMITED (IN) | 2006-09-14 | — | — | US | claimed |
| EP-1565462-A1 | MONOHYDRATE SOLVATES OF LORACARBEF | RANBAXY LABORATORIES, LTD. (IN) | 2005-08-24 | — | — | EP | claimed |
| WO-2004046142-A1 | MONOHYDRATE SOLVATES OF LORACARBEF | RANBAXY LABORATORIES LIMITED (IN) | 2004-06-03 | — | — | WO | claimed |
| CN-1082966-C | Polymer synthesis | DU PONT (US) | 2002-04-17 | — | — | CN | claimed |
| US-6291620-B1 | Polymer synthesis | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-09-18 | — | — | US | claimed |
| EP-0791016-B1 | POLYMER SYNTHESIS | DU PONT (US) | 2000-07-12 | — | — | EP | claimed |
| CN-1162962-A | Polymer synthesis | DU PONT (US) | 1997-10-22 | — | — | CN | claimed |
| EP-0791016-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
| WO-1996015157-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-23 | — | — | WO | claimed |
| US-20230373998-A1 | SOLID STATE FORMS OF LORECIVIVINT | TEVA CZECH INDUSTRIES S.R.O (CZ) | 2023-11-23 | — | — | US | disclosed |
| US-20230295121-A1 | SOLID FORMS OF PRALSETINIB | BLUEPRINT MEDICINES CORPORATION | 2023-09-21 | — | — | US | disclosed |
| US-20230203009-A1 | PRALSETINIB PHARMACEUTICAL COMPOSITIONS | BLUEPRINT MEDICINES CORPORATION | 2023-06-29 | — | — | US | disclosed |
| EP-4157230-A1 | PRALSETINIB PHARMACEUTICAL COMPOSITIONS | Blueprint Medicines Corporation (US) | 2023-04-05 | — | — | EP | disclosed |
| EP-4157829-A1 | SOLID FORMS OF PRALSETINIB | Blueprint Medicines Corporation (US) | 2023-04-05 | — | — | EP | disclosed |
| CN-1027599-C | Method for producing biological functional medical non-woven fabric and product thereof | TEXTILE SCIENT RESEARCH I MINI (CN) | 1995-02-08 | — | — | CN | disclosed |
| CN-1067279-A | The method for making of medical non-woven cloth with organism function and goods thereof | INST OF TEXTILE SCIENCE MINIST (CN) | 1992-12-23 | — | — | CN | disclosed |
| EP-0411751-A1 | Renin inhibitory peptides | Beecham Group p.l.c. (GB) | 1991-02-06 | — | — | EP | disclosed |
| EP-0272061-A3 | CRYSTALLINE CEPHALOSPORIN ANTIBIOTIC SALTS AND SOLVATES | ELI LILLY AND COMPANY (US) | 1990-03-28 | — | — | EP | disclosed |
| EP-0272061-A2 | Crystalline cephalosporin antibiotic salts and solvates | ELI LILLY AND COMPANY (US) | 1988-06-22 | — | — | EP | disclosed |
| US-4734408-A | PURITY | ELI LILLY AND COMPANY (US) | 1988-03-29 | — | — | US | disclosed |